Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded 'Revision: v3.3.3' to the page footer. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe page shows a minor site revision update from v3.2.0 to v3.3.2 in the footer, with no impact on study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the general government funding/operating status disclaimer from the page; the trial record history and details remain intact.SummaryDifference0.3%

- Check64 days agoChange DetectedThe Record History page shows the same core content with a minor visual/layout adjustment to the version list; no new study data or status changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference7%

- Check100 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.2%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.